We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
-1.12%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
AUM
$63.3B
AUM Growth
+$192M
Cap. Flow
+$1.33B
Cap. Flow %
2.1%
Top 10 Hldgs %
14.31%
Holding
4,981
New
573
Increased
1,406
Reduced
1,427
Closed
1,256

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$561M
2
ACN icon
Accenture
ACN
+$435M
3
MRK icon
Merck
MRK
+$378M
4
NOC icon
Northrop Grumman
NOC
+$339M
5
V icon
Visa
V
+$308M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$439M
2
ZTS icon
Zoetis
ZTS
+$345M
3
MCD icon
McDonald's
MCD
+$343M
4
UNH icon
UnitedHealth
UNH
+$334M
5
SPGI icon
S&P Global
SPGI
+$279M

Sector Composition

Rank Sector Weight
1 Technology 17.86%
2 Industrials 11.25%
3 Healthcare 10.23%
4 Financials 10.22%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCTX icon
2676
Lineage Cell Therapeutics
LCTX
$264M
$68.1K ﹤0.01%
68,286
+55,163
+420% +$60.9K
GROY icon
2677
Gold Royalty Corp
GROY
$602M
$68.1K ﹤0.01%
+48,271
New +$85.9K
AGNC icon
2678
AGNC Investment
AGNC
$12.7B
$67.9K ﹤0.01%
+7,117
New +$68.1K
SPSM icon
2679
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$16.9B
$67.4K ﹤0.01%
1,624
+325
+25% +$13.5K
NPCE icon
2680
Neuropace
NPCE
$465M
$66.8K ﹤0.01%
8,833
-36,385
-80% -$367K
CTMX icon
2681
CytomX Therapeutics
CTMX
$690M
$66.6K ﹤0.01%
54,608
-78,591
-59% -$156K
XBIT icon
2682
XBiotech
XBIT
$68.6M
$66.4K ﹤0.01%
12,917
-54,745
-81% -$422K
IOO icon
2683
iShares Global 100 ETF
IOO
$8.62B
$66.3K ﹤0.01%
687
-9,445
-93% -$866K
CGDV icon
2684
Capital Group Dividend Value ETF
CGDV
$36.8B
$66.2K ﹤0.01%
2,005
-68,615
-97% -$2.24M
LOW icon
2685
CALL
Lowe's Companies
LOW
$121B
$66.1K ﹤0.01%
300
-1,400
-82% -$319K
NDLS icon
2686
Noodles & Co
NDLS
$95.1M
$65.4K ﹤0.01%
+5,177
New +$73.8K
Z icon
2687
Zillow
Z
$7.78B
$65K ﹤0.01%
1,402
-245,010
-99% -$10.8M
CAC icon
2688
Camden National
CAC
$988M
$64.8K ﹤0.01%
1,964
+1,514
+336% +$47.8K
GPMT
2689
Granite Point Mortgage Trust
GPMT
$63.7M
$64.7K ﹤0.01%
21,795
+13,985
+179% +$51.8K
LCII icon
2690
LCI Industries
LCII
$2.59B
$64.5K ﹤0.01%
624
-2,852
-82% -$308K
QIPT
2691
DELISTED
Quipt Home Medical
QIPT
$64.3K ﹤0.01%
19,961
-25,520
-56% -$91.6K
BKLC icon
2692
BNY Mellon US Large Cap Core Equity ETF
BKLC
$5.37B
$63.9K ﹤0.01%
1,848
+1,674
+962% +$55.5K
CEPU
2693
Central Puerto
CEPU
$2.16B
$63.9K ﹤0.01%
+7,046
New +$69.2K
AA icon
2694
CALL
Alcoa
AA
$11.3B
$63.6K ﹤0.01%
1,600
-1,900
-54% -$73.5K
LUNG icon
2695
Pulmonx
LUNG
$52.8M
$62.9K ﹤0.01%
9,919
-10,561
-52% -$81.2K
BBUS icon
2696
JPMorgan BetaBuilders US Equity ETF
BBUS
$8.63B
$62.4K ﹤0.01%
636
+38
+6% +$3.59K
LINC icon
2697
Lincoln Educational Services
LINC
$1.38B
$62.3K ﹤0.01%
5,250
-17,277
-77% -$188K
GILT icon
2698
Gilat Satellite Networks
GILT
$789M
$62.2K ﹤0.01%
13,909
+8,320
+149% +$44.3K
GLUE icon
2699
Monte Rosa Therapeutics
GLUE
$1.82B
$62K ﹤0.01%
+16,566
New +$84.5K
VALE icon
2700
CALL
Vale
VALE
$62.3B
$61.4K ﹤0.01%
+5,500
New +$66.1K

Similar funds

Qube Research & Technologies (QRT)'s Q2 2024 Portfolio in Review

As of Q2 2024, Qube Research & Technologies (QRT) held 4,981 positions worth $63.3B, up 0.3% from $63.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Qube Research & Technologies (QRT)'s Q2 2024 filing shows 573 new, 1,406 increased, 1,427 reduced and 1,256 closed positions. Its largest new stake was Coinbase: 273,144 shares worth $60.7M. The largest sale was NVIDIA, an estimated $439M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Industrials and Healthcare.

  • Qube Research & Technologies (QRT)'s largest Q2 2024 buy was Coinbase: 273,144 shares worth $60.7M.
  • Qube Research & Technologies (QRT) added most to Broadcom in Q2 2024, an estimated $561M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2024 reduction was NVIDIA, cutting an estimated $439M.
  • Qube Research & Technologies (QRT) fully exited Palantir in Q2 2024, selling an estimated $161M.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 14% of its $63.3B portfolio in Q2 2024.
  • Qube Research & Technologies (QRT) opened 573 new positions and closed 1,256 in Q2 2024.
  • Qube Research & Technologies (QRT)'s portfolio value rose 0.3% quarter-over-quarter to $63.3B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2024, filed 14 Aug 2024.